Itau Unibanco Holding S.A. Heron Therapeutics, Inc. Transaction History

Itau Unibanco Holding S.A.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$17.42 - $26.61 $7,368 - $11,256	-423 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$16.93 - $26.22 $5,705 - $8,836	-337 Reduced 44.34%	423 $8,000
Q4 2018 Feb 13, 2019	BUY	$22.03 - $32.01 $1,476 - $2,144	67 Added 9.67%	760 $18,000
Q3 2018 Nov 13, 2018	BUY	$30.0 - $40.85 $11,400 - $15,523	380 Added 121.41%	693 $22,000
Q2 2018 Aug 13, 2018	BUY	$26.4 - $42.0 $8,263 - $13,146	313 New	313 $12,000

193

129M

94.7K

148K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $227M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Itau Unibanco Holding S.A. with notifications on news.